Ultima-Tirzepatide 5mg – 1 vial x 5mg – UltimaPeptides USA
Ultima-Tirzepatide 5mg – 1 vial x 5mg – UltimaPeptides USA is a new medication that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is used in the management of type 2 diabetes and is currently being studied to evaluate its potential benefits in weight management.
AI Readiness
Good foundation, but some important product data is still missing.
72%